We are a non-profit education and scientific organization with the aim to aid stakeholders in looking for a diagnosis, preventive methods, and treatment of invasive fungal infections.
Over the years we have successfully been able to work with medical leaders to achieve our purpose. We are committed to faciliating scientific and medical research to help prevent the risk of fungal infections.
We give support to those that are affected by rare diseases. Our mission includes setting educational agendas for mycology and giving the highest quality continuing education to our members and medical practitioners throughout the country.
Our focus is to provide therapy for rare mycoses conditions like cryptococcosis and endemic mycoses such as blastomycosis, histoplasmosis, and coccidioidomycosis.
We carry out studies on invasive mycoses and have helped in the development of a new opportunity for a breakthrough in clinical research.
We have made it our mission to be the leading researchers in evidence-based diagnosis, treatment, and management of fungal infections. We will work to promote research on fungal infections to further our course in providing solutions by offering scholarships.
We will continue to promote the development of antifungal therapies and address problems that are associated with diseases arising as a result of environmental conditions.
Our mission includes:
• To promote innovation through education in developing evidence-based medical expertise on fungal infections.
• To provide a forum for sharing knowledge amongst mycology physicians, scientists and researchers.
• To provide training for young innovators through our workshops and clinical trials.
• To bring mycology investigators, scientists, practitioners, epidemiologists, and other professionals together to address research questions and developing clinical investigations.
• To conduct diagnostic tests on invasive mycoses and developing new therapies for these conditions.
• To contribute to evidence-based practice literature by providing books and manuscripts to develop a diagnosis.
We will continue to partner with government agencies and practitioners to support clinical mycology.